It also helps in sustaining even skin tone
April 30, 2026 regulatory update: On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list for outsourcing facilities, finding no clinical need for large-scale compounding of those substances
Appetite and Satiety : By activating GLP-1 and GIP receptors, Zepbound slows down digestion, reduces appetite, and prolongs the feeling of fullness, helping users to eat less over time
Hear from our co-founder Becca McCarthy on building GLP-1 before the boom, leading as a female founder in a breakthrough category, and why this is about more than weight loss
R.MamminoK.NoceraJ
Akkermansia muciniphila ) as well as Firmicutes ( Clostridiales , Oscillospiraceae )